# Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome

> **NCT05183178** · PHASE4 · UNKNOWN · sponsor: **Vastra Gotaland Region** · enrollment: 16000 (estimated)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Prasugrel 10 mg p.o
- **DRUG:** Ticagrelor 90 mg

## Key facts

- **NCT ID:** NCT05183178
- **Lead sponsor:** Vastra Gotaland Region
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-01
- **Primary completion:** 2025-01-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 16000 (ESTIMATED)
- **Last updated:** 2022-03-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05183178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05183178, "Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05183178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*